Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program.

Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program. Abstract Text:

Two groups totaling 162 patients hospitalized for modified Goeckerman treatment of severe psoriasis were matched for sex, age, and season of admission and followed up for two years after discharge. One group remained hospitalized throughout their average 20.8-day course; the other half was hospitalized 14 days, then transferred to an ambulatory center for the remainder of a course averaging 20.8 days. No difference was detected between the groups in the duration that improvement equaled or exceeded progress achieved at discharge. The percentage of patients remaining continuously improved after discharge was 80% at one month, 55% at six months, 40% at 12 months, and 20% at 24 months. rates of relapse requiring readmission or alternate therapy were also similar: 75% had not relapsed by 12 months and 60% had not relapsed by 24 months.

Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program. Publishing Authors By Initials

For similar complex mixtures: tars research abstracts see: complex mixtures: tars research

PUBMED ID PMID:

MEDLINE DATE:

Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Archives of dermatology

VOLUME: 120

Page Numbers: 313-8

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Mar

YEAR: 1984

Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program. Keywords Mesh Terms:

KEYWORDS: Tars

MESH TERMS: administration & dosage

Chemical & Substance for Abstract: Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program. Information

Substance Name: Tars

Registry Number: 0

Grant and Affiliation Information for Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program.

AFFILIATION:

Country: UNITED STATES

AGENCY: United States NCRR

GRANT: RR645-08

ACRONYM: RR

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Modified Goeckerman therapy for psoriasis A two-year follow-up of a combined hospital-ambulatory care program Related Publications

• Chromblastomycosis treated with local infiltration of amphotericin B solution. Report of second case.
• Erythropoietic protoporphyria.
• Hydroa vacciniforme.
• Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin.
• Modified Goeckerman therapy for psoriasis. A two-year follow-up of a combined hospital-ambulatory care program.
• Photobiology of lupus erythematosus.
• Rapid quantitative assay for erythrocyte porphyrins.
• Reflections and perspectives concerning cutaneous photobiology.
• Solar urticaria. Clinical features and wavelength dependence.
• Symptoms, ventilatory function, and environmental exposures in Portland cement workers.
• The Case mid R: Allograft dysfunction in a patient with sickle cell disease.
• The new workplace accommodation guidelines.
• Using the balanced scorecard to mobilize human resources in organizational transformation.